Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study

BACKGROUND: Patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, may develop extraintestinal manifestations (EIMs). The EMOTIVE study aimed to analyze the effect of vedolizumab on EIMs in a real-world cohort of patients with IBD. METHODS: This multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopylov, Uri, Burisch, Johan, Ben-Horin, Shomron, Braegger, Fiona, Fernández-Nistal, Alonso, Lara, Nuria, Heinrich, Henriette Sophie, Vavricka, Stephan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628928/
https://www.ncbi.nlm.nih.gov/pubmed/37158585
http://dx.doi.org/10.1093/ibd/izad075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628928/
https://www.ncbi.nlm.nih.gov/pubmed/37158585
http://dx.doi.org/10.1093/ibd/izad075

Ejemplares similares